Ameritek Ventures Files Q2 2025 10-Q

TL;DR

Ameritek Ventures filed its Q2 2025 10-Q. Check financials.

AI Summary

Ameritek Ventures, Inc. filed its quarterly report on Form 10-Q for the period ending June 30, 2025. The company, incorporated in Nevada and operating in the motor vehicle parts & accessories sector, is headquartered in Reno, NV. This filing provides an update on its financial status and business operations for the second quarter of 2025.

Why It Matters

This filing provides investors with an update on Ameritek Ventures' financial performance and operational status for the second quarter of 2025, crucial for assessing the company's current health and future prospects.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information that could reveal significant positive or negative developments, impacting investment decisions.

Key Numbers

• 2025 Q2 — Reporting Period (Second quarter of 2025 financial data)
• 2025-06-30 — Period End Date (The end date for the financial reporting period)
• 2025-08-15 — Filing Date (The date the report was officially submitted to the SEC)

Key Players & Entities

• Ameritek Ventures, Inc. (company) — Filer of the 10-Q
• 20250630 (date) — End of the reporting period
• 20250815 (date) — Filing date
• Reno, NV (location) — Company headquarters
• 3714 (industry_code) — Standard Industrial Classification for Motor Vehicle Parts & Accessories

FAQ

Key Financial Figures

• $7.69 — sing price of ZenaTech common stock was $7.69 per share at the reporting date. Ecker
• $1,000 — ttoMask did not generate profit of over $1,000 in 2024. 2. SUMMARY OF ACCOUNTING PRIN
• $4,000 — on expense on intangible assets totaled $4,000 for the six months ended June 30, 2025,
• $16,000 — the six months ended June 30, 2025, and $16,000 for the year ended December 31, 2024.
• $ — t the exchange rate of 1.2691 $US to CAN$, as listed by https://www.poundsterling
• $661,887 — undsterlinglive.com/. Ameritek realized $661,887 revenue from this sale equally from the

Filing Documents

• atvk-20250630_10q.htm (10-Q) — 799KB
• av_ex31z1.htm (EX-31.1) — 16KB
• av_ex31z2.htm (EX-31.2) — 16KB
• av_ex32z1.htm (EX-32.1) — 9KB
• av10q_1.jpg (GRAPHIC) — 75KB
• 0001376474-25-000754.txt ( ) — 4523KB
• atvk-20250630_cal.xml (EX-101.CAL) — 33KB
• atvk-20250630_def.xml (EX-101.DEF) — 139KB
• atvk-20250630_lab.xml (EX-101.LAB) — 222KB
• atvk-20250630_pre.xml (EX-101.PRE) — 202KB
• atvk-20250630.xsd (EX-101.SCH) — 49KB
• atvk-20250630_10q_htm.xml (XML) — 735KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets (unaudited) 5 Condensed Consolidated Statements of Operations (unaudited) 6 Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) 7 Condensed Consolidated Statements of Cash Flows (unaudited) 8 Notes to Condensed Consolidated Financial Statements (unaudited) 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 21 Item 4.

Controls and Procedures

Controls and Procedures 21

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 23 Item 1A.

Risk Factors

Risk Factors 23 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23 Item 3. Defaults Upon Senior Securities 23 Item 4. Mine Safety Disclosures 23 Item 5. Other Information 23 Item 6. Exhibits 23

Signatures

Signatures 24 3 4 AMERITEK VENTURES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) As of As of June 30, December 31, 2025 2024 ASSETS Current assets: Cash $ 1,138 $ - Accounts receivable, net - - Prepaid expense - - Total current assets 1,138 - Property and equipment, net - - Long-term assets: Commitment fees (lines of credit) 24,024 27,720 Investment in securities 6,757,719 14,053,981 Patent 250,000 250,000 Product development, net 100,001 104,001 Goodwill 1,771,676 1,771,676 Total long-term assets 8,903,420 16,207,378 Total assets $ 8,904,558 $ 16,207,378 LIABILITIES AND STOCKHOLDER'S EQUITY Current liabilities: Accounts payable $ 505,250 $ 516,350 Short-term advance from affiliate 317,893 317,793 Accrued interest and expenses 650,324 600,032 Short-term debt 21,000 21,000 Total current liabilities 1,494,467 1,455,175 Long-term liabilities: Long term debts 1,046,837 1,022,411 Total liabilities 2,541,304 2,477,586 Stockholders' equity (deficit): Preferred stock Series A, $ 0.01 par value, 10,000,000 shares authorized, 7,488,730 issued and outstanding, respectively 74,887 74,887 Preferred stock Series B, $ 0.01 par value, 10,000,000 shares authorized, 10,000,000 issued and outstanding, respectively 100,000 100,000 Preferred stock Series C, $ 0.01 par value, 60,000,000 shares authorized, 59,988,972 and 59,988,972 issued and outstanding, at end of period and start of period respectively 599,890 599,890 Preferred stock Series D, $ 0.01 par value, 10,000,000 shares authorized, 9,083,630 issued and outstanding, respectively 90,836 90,836 Preferred stock Series E, $ 0.01 par value, 23,000,000 shares authorized, 23,000,000 issued and outstanding, respectively 230,000 230,000 Common stock, $ 0.001 par value, 950,000,000 shares authorized, 949,226,791 and 613,226,791 issued and outstanding, respectively

View Full Filing

View this 10-Q filing on SEC EDGAR